ATE409041T1 - Weibliche verhütungmethode und pharmazeutische zubereitungen die für eine solche methode geeignet sind - Google Patents

Weibliche verhütungmethode und pharmazeutische zubereitungen die für eine solche methode geeignet sind

Info

Publication number: ATE409041T1
Authority: AT; Austria
Prior art keywords: estradiol; beta; estrogen; amount equivalent; progestogen
Prior art date: 2003-03-28

Application number

AT03075905T

Other languages

English (en)

Inventor

Bennink Herman Jan Tijmen Coelingh

Monique Visser

Original Assignee

Pantarhei Bioscience Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-28

Filing date

2003-03-28

Publication date

2008-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32798964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE409041(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-03-28 Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE409041T1 publication Critical patent/ATE409041T1/de

Links

238000000034 method Methods 0.000 title abstract 4
239000000825 pharmaceutical preparation Substances 0.000 title 1
VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 12
229960005309 estradiol Drugs 0.000 abstract 6
229940011871 estrogen Drugs 0.000 abstract 5
239000000262 estrogen Substances 0.000 abstract 5
239000000583 progesterone congener Substances 0.000 abstract 3
JGMOKGBVKVMRFX-HQZYFCCVSA-N dydrogesterone Chemical compound C1=CC2=CC(=O)CC[C@@]2(C)[C@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 JGMOKGBVKVMRFX-HQZYFCCVSA-N 0.000 abstract 2
229960004913 dydrogesterone Drugs 0.000 abstract 2
239000002243 precursor Substances 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Packaging Of Special Articles (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03075905T 2003-03-28 2003-03-28 Weibliche verhütungmethode und pharmazeutische zubereitungen die für eine solche methode geeignet sind ATE409041T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03075905A EP1462107B1 (de)	2003-03-28	2003-03-28	Weibliche Verhütungmethode und pharmazeutische Zubereitungen die für eine solche Methode geeignet sind

Publications (1)

Publication Number	Publication Date
ATE409041T1 true ATE409041T1 (de)	2008-10-15

Family

ID=32798964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03075905T ATE409041T1 (de)	2003-03-28	2003-03-28	Weibliche verhütungmethode und pharmazeutische zubereitungen die für eine solche methode geeignet sind

Country Status (7)

Country	Link
EP (1)	EP1462107B1 (de)
AT (1)	ATE409041T1 (de)
DE (1)	DE60323725D1 (de)
DK (1)	DK1462107T3 (de)
ES (1)	ES2314156T3 (de)
PT (1)	PT1462107E (de)
SI (1)	SI1462107T1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4344462C2 (de)	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
WO2006036055A2 (en) *	2004-09-27	2006-04-06	Pantarhei Bioscience B. V.	Method of female contraception and kit for use in such method
TW200727920A (en) *	2005-06-21	2007-08-01	Organon Nv	New regimens for oral monophasic contraceptives
DE102005034498A1 (de) *	2005-07-20	2007-01-25	Grünenthal GmbH	Orale Kontrazeption mit Trimegeston

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4383993A (en) *	1980-05-30	1983-05-17	University Of Kentucky Research Foundation	Nasal dosage forms containing natural female sex hormones
SE9403389D0 (sv) *	1994-10-06	1994-10-06	Astra Ab	Pharmaceutical composition containing derivattves of sex hormones
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6265393B1 (en) *	1998-08-07	2001-07-24	Heinrichs William Leroy	Prevention of endometriosis signs or symptons
CA2446849A1 (en) *	2001-05-16	2002-11-21	Endeavor Pharmaceuticals	Treatment of conditions relating to hormone deficiencies by administration of progestins
ATE254465T1 (de) *	2001-05-23	2003-12-15	Pantarhei Bioscience Bv	Zubereitungen für die hormonale kontrazeption
WO2002094277A1 (en) *	2001-05-23	2002-11-28	Pantarhei Bioscience B.V.	Means and method for hormonal contraception
WO2003041719A1 (en) *	2001-11-15	2003-05-22	Pantarhei Bioscience B.V.	Method of contraception in mammalian females and pharmaceutical kit for use in such method

2003
- 2003-03-28 AT AT03075905T patent/ATE409041T1/de not_active IP Right Cessation
- 2003-03-28 EP EP03075905A patent/EP1462107B1/de not_active Expired - Lifetime
- 2003-03-28 SI SI200331473T patent/SI1462107T1/sl unknown
- 2003-03-28 DK DK03075905T patent/DK1462107T3/da active
- 2003-03-28 ES ES03075905T patent/ES2314156T3/es not_active Expired - Lifetime
- 2003-03-28 PT PT03075905T patent/PT1462107E/pt unknown
- 2003-03-28 DE DE60323725T patent/DE60323725D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60323725D1 (de)	2008-11-06
SI1462107T1 (sl)	2009-02-28
PT1462107E (pt)	2009-01-02
EP1462107A1 (de)	2004-09-29
EP1462107B1 (de)	2008-09-24
DK1462107T3 (da)	2008-11-03
ES2314156T3 (es)	2009-03-16

Similar Documents

Publication	Publication Date	Title
Bevelander et al.	1961	The effect of the administration of tetracycline on the development of teeth
ES2185179T3 (es)	2003-04-16	Preparacion de composiciones farmaceuticas.
CO5251419A1 (es)	2003-02-28	Composiciones nanoparticuladas de eplerenona
CO5190672A1 (es)	2002-08-29	Composicion para la dosificacion oral, de disolucion instantanea
EP1275381A4 (de)	2007-05-02	Feste überzogene zubereitungen mit zeitabhängiger freisetzung zur oralen verabreichung
ES2170069T3 (es)	2002-08-01	1-alfa-hidroxiprevitamina d para administracion oral.
DK0785775T3 (da)	2004-05-24	Smelteekstruderede oralt administrerbare opioid-formuleringer
BR0015188A (pt)	2002-11-05	Composições farmacêuticas
BR0010498A (pt)	2002-02-26	Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos
BR9808888A (pt)	2000-10-03	Formas de dosagem e método de melhorar disfunção erétil masculina
BR0014159A (pt)	2002-05-07	Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
PT911029E (pt)	2002-09-30	Contraceptivos orais em doses ultra-baixas com menos hemorragias menstruais e com eficacia prolongada
NZ591627A (en)	2012-09-28	Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
YU2703A (sh)	2006-03-03	Bistar vodeni anestetski preparat
BR0114665A (pt)	2004-01-13	Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
AR009113A1 (es)	2000-03-08	UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
AR035946A1 (es)	2004-07-28	Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
DE60323725D1 (de)	2008-11-06	Weibliche Verhütungmethode und pharmazeutische Zubereitungen die für eine solche Methode geeignet sind
Katz et al.	1986	Burning mouth sensation associated with fusospirochetal infection in edentulous patients
EP1051162B1 (de)	2006-04-05	Verfahren und kits zur behandlung von vulvovaginalen candidosen mit mikonazolnitrat
HRP20020258B1 (hr)	2007-05-31	Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
JPS61176524A (ja)	1986-08-08	抗炎症組成物
EA200701091A1 (ru)	2008-02-28	Противозачаточный фармацевтический препарат
ATE212840T1 (de)	2002-02-15	Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung

Legal Events

Date

Code

Title

Description

2009-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1462107

Country of ref document: EP

2010-06-15

REN

Ceased due to non-payment of the annual fee